Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.

Moshaver B, Wouters RF, Kelder A, Ossenkoppele GJ, Westra GAH, Kwidama Z, Rutten AR, Kaspers GJL, Zweegman S, Cloos J, Schuurhuis GJ.

Leuk Res. 2019 Jun;81:27-34. doi: 10.1016/j.leukres.2019.04.004. Epub 2019 Apr 9.

PMID:
31002948
2.

Flow cytometric analysis of viable bacteria in urine samples of febrile patients at the emergency department.

Tavenier AH, de Boer FJ, Moshaver B, van der Leur SJCM, Stegeman CA, Groeneveld PHP.

Cytometry B Clin Cytom. 2018 Sep;94(5):689-695. doi: 10.1002/cyto.b.21548. Epub 2017 Aug 23.

3.

Accurate and fast urinalysis in febrile patients by flow cytometry.

de Boer FJ, Gieteling E, van Egmond-Kreileman H, Moshaver B, van der Leur SJ, Stegeman CA, Groeneveld PH.

Infect Dis (Lond). 2017 May;49(5):380-387. doi: 10.1080/23744235.2016.1274048. Epub 2017 Jan 11.

PMID:
28077007
4.

Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.

Westers TM, Cremers EM, Oelschlaegel U, Johansson U, Bettelheim P, Matarraz S, Orfao A, Moshaver B, Brodersen LE, Loken MR, Wells DA, Subirá D, Cullen M, Te Marvelde JG, van der Velden VH, Preijers FW, Chu SC, Feuillard J, Guérin E, Psarra K, Porwit A, Saft L, Ireland R, Milne T, Béné MC, Witte BI, Della Porta MG, Kern W, van de Loosdrecht AA; IMDSFlow Working Group.

Haematologica. 2017 Feb;102(2):308-319. doi: 10.3324/haematol.2016.147835. Epub 2016 Oct 6.

5.

Fast and accurate prediction of positive and negative urine cultures by flow cytometry.

Moshaver B, de Boer F, van Egmond-Kreileman H, Kramer E, Stegeman C, Groeneveld P.

BMC Infect Dis. 2016 May 17;16:211. doi: 10.1186/s12879-016-1557-4.

6.
7.

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.

van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, Bettelheim P, Bowen DT, Burbury K, Eidenschink L, Cazzola M, Chu SS, Cullen M, Cutler JA, Dräger AM, Feuillard J, Fenaux P, Font P, Germing U, Haase D, Hellström-Lindberg E, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Nikolova V, Ogata K, Oelschlaegel U, Orfao A, Ossenkoppele GJ, Porwit A, Platzbecker U, Preijers F, Psarra K, Richards SJ, Subirá D, Seymour JF, Tindell V, Vallespi T, Valent P, van der Velden VH, Wells DA, de Witte TM, Zettl F, Béné MC, Westers TM.

Leuk Lymphoma. 2013 Mar;54(3):472-5. doi: 10.3109/10428194.2012.718341. Epub 2012 Sep 14. Review.

PMID:
22916713
8.

OMIP-010: a new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples.

Preijers FW, Huys E, Moshaver B.

Cytometry A. 2012 Jun;81(6):453-5. doi: 10.1002/cyto.a.22056. Epub 2012 Apr 24. No abstract available.

9.

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group.

Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury K, Cullen M, Cutler JA, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Johansson U, Kordasti S, Loken MR, Malcovati L, te Marvelde JG, Matarraz S, Milne T, Moshaver B, Mufti GJ, Ogata K, Orfao A, Porwit A, Psarra K, Richards SJ, Subirá D, Tindell V, Vallespi T, Valent P, van der Velden VH, de Witte TM, Wells DA, Zettl F, Béné MC, van de Loosdrecht AA.

Leukemia. 2012 Jul;26(7):1730-41. doi: 10.1038/leu.2012.30. Epub 2012 Feb 6.

PMID:
22307178
10.

Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS.

Westers TM, van der Velden VH, Alhan C, Bekkema R, Bijkerk A, Brooimans RA, Cali C, Dräger AM, de Haas V, Homburg C, de Jong A, Kuiper-Kramer PE, Leenders M, Lommerse I, te Marvelde JG, van der Molen-Sinke JK, Moshaver B, Mulder AB, Preijers FW, Schindhelm RK, van der Sluijs A, van Wering ER, Westra AH, van de Loosdrecht AA; Working Party on Flow Cytometry in MDS of Dutch Society of Cytometry (NVC).

Leuk Res. 2012 Apr;36(4):422-30. doi: 10.1016/j.leukres.2011.09.015. Epub 2011 Oct 6.

PMID:
21982641
11.

The new violet laser dye, Krome Orange, allows an optimal polychromatic immunophenotyping based on CD45-KO gating.

Preijers FW, Huys E, Leenders M, Nieto L, Gautherot E, Moshaver B.

J Immunol Methods. 2011 Sep 30;372(1-2):42-51. doi: 10.1016/j.jim.2011.06.025. Epub 2011 Jul 14.

PMID:
21781971
12.

Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.

Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ.

Stem Cells. 2008 Dec;26(12):3059-67. doi: 10.1634/stemcells.2007-0861.

13.

Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival.

Moshaver B, van der Pol MA, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ.

Leuk Lymphoma. 2008 Jan;49(1):134-48.

PMID:
17926185
14.

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells.

van Rhenen A, van Dongen GA, Kelder A, Rombouts EJ, Feller N, Moshaver B, Stigter-van Walsum M, Zweegman S, Ossenkoppele GJ, Jan Schuurhuis G.

Blood. 2007 Oct 1;110(7):2659-66. Epub 2007 Jul 3.

PMID:
17609428
15.

Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.

van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S, Ossenkoppele GJ, Schuurhuis GJ.

Leukemia. 2007 Aug;21(8):1700-7. Epub 2007 May 24.

PMID:
17525725
16.

New approaches for the detection of minimal residual disease in acute myeloid leukemia.

van Rhenen A, Moshaver B, Ossenkoppele GJ, Schuurhuis GJ.

Curr Hematol Malig Rep. 2007 May;2(2):111-8. doi: 10.1007/s11899-007-0016-0. Review.

PMID:
20425359
17.

Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cells.

van der Pol MA, Feller N, Roseboom M, Moshaver B, Westra G, Broxterman HJ, Ossenkoppele GJ, Schuurhuis GJ.

Haematologica. 2003 Sep;88(9):983-93.

18.

Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.

Mulder CJ, Wahab PJ, Moshaver B, Meijer JW.

Scand J Gastroenterol Suppl. 2000;(232):32-7. Review.

PMID:
11232488

Supplemental Content

Loading ...
Support Center